Pancreatic Exocrine Insufficiency Following Esophagectomy, Gastrectomy and Bariatric Surgery: A Systematic Review and Narrative Synthesis
- 12 November 2026
- journal article
- review article
- Published by Wiley in World Journal of Surgery
Abstract
Background: Pancreatic exocrine insufficiency (PEI) is an increasingly recognised consequence of esophagogastric surgery; however, its prevalence, burden across different surgical procedures, and optimal approaches to diagnosis and management remain incompletely characterized. This review aims to systematically evaluate the prevalence, diagnosis, clinical manifestations, nutritional consequences and management of PEI following esophagogastric surgery in adults. Methods: A systematic review and meta‐analysis was conducted according to Joanna Briggs Institute methodology and reported in accordance with PRISMA 2020. PubMed, Scopus, Web of Science and Embase were searched from January 2011 to May 2026. Eligible studies reported PEI following esophagectomy, gastrectomy, or bariatric surgery. Owing to substantial clinical and methodological heterogeneity, findings were synthesized narratively by surgical group and procedure. Risk of bias was evaluated using JBI critical appraisal tools. Results: Seventeen studies comprising 1397 patients were included. Reported PEI prevalence varied substantially across surgical populations, ranging from 3.2% to 22.0% following esophagectomy, 25.0%–63.8% following gastrectomy, and 9.1%–32.6% in bariatric cohorts. Procedure‐specific estimates varied considerably, with rates of 4.2%–17.2% following sleeve gastrectomy, 8.3%–10.3% following RYGB, 48.1% following distal RYGB and 75.0% following biliopancreatic diversion with duodenal switch. Fecal elastase‐1 was the most frequently used diagnostic test, although diagnostic criteria and timing of assessment varied between studies. Gastrointestinal symptoms, weight loss, nutritional deficiencies and impaired quality of life were reported, while limited observational evidence suggested symptomatic improvement following pancreatic enzyme replacement therapy. Conclusions: PEI is an under‐recognised consequence of esophagectomy, gastrectomy and bariatric surgery, with reported prevalence varying substantially between procedures and studies. Greater clinical awareness and standardised approaches to diagnosis are required, alongside prospective studies to better define postoperative screening and management. Trial Registration: This review was prospectively registered in PROSPERO (CRD420261369499)This publication has 24 references indexed in Scilit:
- Fat malabsorption and reduced exocrine pancreatic function after gastroesophageal cancer surgeryJournal of Gastrointestinal Surgery, 2026
- European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendationsUnited European Gastroenterology Journal, 2024
- Exocrine pancreatic insufficiency and pancreatic exocrine replacement therapy in clinical practiceNutrition in Clinical Practice, 2024
- Exocrine pancreatic insufficiency after bariatric surgeryPancreatology, 2022
- Pancreatic exocrine insufficiency after bariatric surgerySurgery for Obesity and Related Diseases, 2022
- Exocrine pancreatic function and dynamic of digestion after restrictive and malabsorptive bariatric surgery: a prospective, cross-sectional, and comparative studySurgery for Obesity and Related Diseases, 2021
- Exocrine pancreatic insufficiency in long-term follow-up after curative gastric resection with D2 lymphadenectomy: A cross-sectional studyPancreatology, 2021
- Nutritional deficiency post esophageal and gastric cancer surgery: A quality improvement studyAnnals of Medicine & Surgery, 2020
- Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2018
- Exocrine Pancreatic Insufficiency after Roux-en-Y gastric bypassSurgery for Obesity and Related Diseases, 2016